5966 related articles for article (PubMed ID: 2470106)
61. Identification and isolation of melanoma-associated antigens with monoclonal antibodies.
Ross AH; Mitchell KF; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(4):413-21. PubMed ID: 6765324
[TBL] [Abstract][Full Text] [Related]
62. Protective, anti-tumor monoclonal antibody recognizes a conformational epitope similar to melibiose at the surface of invasive murine melanoma cells.
Dobroff AS; Rodrigues EG; Moraes JZ; Travassos LR
Hybrid Hybridomics; 2002 Oct; 21(5):321-31. PubMed ID: 12470474
[TBL] [Abstract][Full Text] [Related]
63. Characterization and biodistribution of a mouse/human chimeric antibody directed against pancreatic cancer mucin.
Hirayama K; Chung YS; Sawada T; Kim YS; Sowa M
Cancer; 1995 Mar; 75(6 Suppl):1545-53. PubMed ID: 7889489
[TBL] [Abstract][Full Text] [Related]
64. Suppression of tumor growth by in vivo administration of a recombinant human-mouse chimeric monoclonal antibody.
Yokoyama M; Nishimura Y; Watanabe T
Jpn J Cancer Res; 1987 Nov; 78(11):1251-7. PubMed ID: 2961718
[TBL] [Abstract][Full Text] [Related]
65. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
66. A human monoclonal antimelanoma single-chain Fv antibody derived from tumor-infiltrating lymphocytes.
Zhang H; Lake DF; Barbuto JA; Bernstein RM; Grimes WJ; Hersh EM
Cancer Res; 1995 Aug; 55(16):3584-91. PubMed ID: 7627967
[TBL] [Abstract][Full Text] [Related]
67. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
68. Characterization of a human T cell-specific chimeric antibody (CD7) with human constant and mouse variable regions.
Heinrich G; Gram H; Kocher HP; Schreier MH; Ryffel B; Akbar A; Amlot PL; Janossy G
J Immunol; 1989 Dec; 143(11):3589-97. PubMed ID: 2479683
[TBL] [Abstract][Full Text] [Related]
69. Syngeneic monoclonal anti-melanoma antibody that inhibits experimental lung metastasis of B16 melanoma.
Gunji Y; Taniguchi M
Jpn J Cancer Res; 1986 Jun; 77(6):595-601. PubMed ID: 3089994
[TBL] [Abstract][Full Text] [Related]
70. Structure and epitope specificity of human melanoma-associated oncofetal antigen gp87 analyzed with monoclonal antibodies.
Liao SK; Leung WC; Kanamaru T
J Dermatol; 1985 Apr; 12(2):117-28. PubMed ID: 2411774
[No Abstract] [Full Text] [Related]
71. Production and characterization of monoclonal antibodies against human malignant melanoma.
Herlyn M; Steplewski Z; Herlyn D; Clark WH; Ross AH; Blaszczyk M; Pak KY; Koprowski H
Cancer Invest; 1983; 1(3):215-24. PubMed ID: 6667406
[TBL] [Abstract][Full Text] [Related]
72. Tissue distribution of a melanoma-associated antigen immunogenic in patients with melanoma as analyzed by polyclonal antibodies to recombinant peptide antigen.
Kako S; Hayashibe K; Ichihashi M
J Dermatol; 1996 Apr; 23(4):230-7. PubMed ID: 8935336
[TBL] [Abstract][Full Text] [Related]
73. Recombinant anti-human melanoma antibodies are versatile molecules.
Neri D; Natali PG; Petrul H; Soldani P; Nicotra MR; Vola R; Rivella A; Creighton AM; Neri P; Mariani M
J Invest Dermatol; 1996 Aug; 107(2):164-70. PubMed ID: 8757757
[TBL] [Abstract][Full Text] [Related]
74. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.
Brown JP; Woodbury RG; Hart CE; Hellström I; Hellström KE
Proc Natl Acad Sci U S A; 1981 Jan; 78(1):539-43. PubMed ID: 6165996
[TBL] [Abstract][Full Text] [Related]
75. Cross-reactivity between murine melanoma antigen B700 and a human melanoma-associated antigen (M-66) recognized by autologous antibody: evidence suggesting shared epitopes.
Toporowicz A; Gersten DM; Hearing VJ; Brown WE; Vlock DR
Biochim Biophys Acta; 1993 Aug; 1182(1):51-6. PubMed ID: 7688577
[TBL] [Abstract][Full Text] [Related]
76. Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration.
Oldham RK; Foon KA; Morgan AC; Woodhouse CS; Schroff RW; Abrams PG; Fer M; Schoenberger CS; Farrell M; Kimball E
J Clin Oncol; 1984 Nov; 2(11):1235-44. PubMed ID: 6333489
[TBL] [Abstract][Full Text] [Related]
77. Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies.
Nakazawa Y; Takagi S; Sato S; Oh-hara T; Koike S; Takami M; Arai H; Fujita N
Cancer Sci; 2011 Nov; 102(11):2051-7. PubMed ID: 21824222
[TBL] [Abstract][Full Text] [Related]
78. Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97.
Casellas P; Brown JP; Gros O; Gros P; Hellström I; Jansen FK; Poncelet P; Roncucci R; Vidal H; Hellström KE
Int J Cancer; 1982 Oct; 30(4):437-43. PubMed ID: 7141740
[TBL] [Abstract][Full Text] [Related]
79. Immunodiagnostic and immunotherapeutic applications of anti human melanoma associated antigen monoclonal antibodies.
Natali PG; Fawwaz R; Ruiter DJ; Bigotti A; Kageshita T; Temponi M; Ferrone S
Carcinog Compr Surv; 1989; 11():133-63. PubMed ID: 2646014
[No Abstract] [Full Text] [Related]
80. Mouse-human chimeric antibody MH171 against the multidrug transporter P-glycoprotein.
Ariyoshi K; Hamada H; Naito M; Heike Y; Seimiya H; Maezawa K; Tsuruo T
Jpn J Cancer Res; 1992 May; 83(5):515-21. PubMed ID: 1352281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
